Express Pharma - Page 45 of 2246 - Express Pharma

Lilly’s retatrutide shows greater A1C reduction and weight loss than Ozempic in Phase 3 trial

Spektus Pharma, GEBRO partner to commercialise ActraFlex globally

DoP conducts 14,700 cleanliness drives under SCDPM 6.0

USFDA and EUDRA dashboards offer lessons for strengthening India’s regulatory transparency

From fintech to aesthetic injectables: Lessons in navigating regulatory formalisation

Karnataka holds 64th Vision Group on Biotechnology meeting to review biotech ecosystem

Glenmark launches Methylene Blue Injection USP in US

ILAMED expands international presence with centres in Kenya, Ethiopia and Thailand

Novartis India launches Pluvicto for PSMA-positive metastatic prostate cancer

Alembic receives USFDA final approval for Tretinoin Cream USP, 0.05%

Ipca Laboratories and Bhami’s Research Laboratory signs global licensing agreement for subcutaneous biologics platform

CDSCO’s cosmetic regulations: The rules exist. The enforcement does not

Why ingredient transparency matters more than ever in cosmeceuticals